FedTALLY

Awards for “RAFA LABORATORIES LTD

9 awards on this page · sorted by amount · page 1

Award IDRecipientAwarding agencyAmountStartEndNAICSDescription
75A50325C00020RAFA LABORATORIES LTDDepartment of Health and Human Services$33.39M
2025-09-302027-09-29325412RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
HHSD2002017925240003RAFA LABORATORIES LTDDepartment of Health and Human Services$32.27M
2018-03-092019-05-29325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ
HHSD2002017925240002RAFA LABORATORIES LTDDepartment of Health and Human Services$27.95M
2017-06-302018-07-31325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ
75A50121F33006RAFA LABORATORIES LTDDepartment of Health and Human Services$22.5M
2021-09-222022-06-30325412RAFA DO 6
75A50119F33004RAFA LABORATORIES LTDDepartment of Health and Human Services$15.95M
2019-08-082020-05-31325412TASK ORDER FOR ADDITIONAL PRODUCTS
75A50125C00018RAFA LABORATORIES LTDDepartment of Health and Human Services$11.77M
2025-09-292036-06-30541714THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA
75A50123C00055RAFA LABORATORIES LTDDepartment of Health and Human Services$9.37M
2023-09-192028-08-04541714THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI
75A50120F33005RAFA LABORATORIES LTDDepartment of Health and Human Services$7.81M
2020-09-292021-03-31325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE
HHSD2002017925240001RAFA LABORATORIES LTDDepartment of Health and Human Services$7.05M
2017-01-312017-09-15325412ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - TO1